Final results of a prospective, observational study of the effectiveness of darbepoetin alfa administered every three weeks for the treatment of chemotherapy-induced anaemia in elderly patients

被引：0
|
作者：
Esquerdo, G.
Domenech, M.
Bermejo, J. C.
Lopez, P.
Pedro, C.
Villadiego, K.
Constenla, M.
Sanchez-Rovira, P.
Gasquet, J. A.
Rodriguez, C. A.
机构：
[1] Clin Benidorm, Barcelona, Spain
[2] Althaia, Barcelona, Spain
[3] H Sagrat Cor, Barcelona, Spain
[4] H Virgen Nieves, Granada, Spain
[5] H del Mar, Barcelona, Spain
[6] H Pontevedra, Pontevedra, Spain
[7] H Jaen, Jaen, Spain
[8] Amgen SA, Barcelona, Spain
[9] H Univ Salamanca, Salamanca, Spain
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2009年 / 27卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e20654
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Pharmacokinetic evaluation of darbepoetin alfa for the treatment of pediatric patients with chemotherapy-induced anemia
    Blumer, Jeffrey
    Berg, Stacey
    Adamson, Peter C.
    Loew, Thomas
    Rossi, Greg
    Hastings, Caroline
    PEDIATRIC BLOOD & CANCER, 2007, 49 (05) : 687 - 693
  • [42] Evaluation of clinical use and effectiveness of darbepoetin alfa in cancer patients with chemotherapy-induced anemia
    Bustos, Aurelia
    Alvarez, Ruth
    Miguel Aramburo, Pedro
    Carabantes, Francisco
    Diaz, Nieves
    Florian, Jesus
    Lazaro, Martin
    Maria Martin de Segovia, Jose
    Antonio Gasquet, Jose
    Alegre, Adrian
    CURRENT MEDICAL RESEARCH AND OPINION, 2012, 28 (01) : 57 - 67
  • [43] Results of darbepoetin alfa treatment of anaemia in chemotherapy-receiving breast cancer patients: a single-centre retrospective observational study
    Jagiello-Gruszfeld, Agnieszka
    Niwinska, Anna
    Michalski, Wojciech
    Pogoda, Katarzyna
    Dubianski, Roman
    Kunkiel, Michal
    Lemanska, Izabela
    Sienkiewicz, Renata
    Gorniak, Anna
    Kosakowska, Ewa
    Nowecki, Zbigniew
    ONCOLOGY IN CLINICAL PRACTICE, 2021, 17 (06): : 237 - 243
  • [44] A randomized comparison of darbepoetin alfa every three weeks with epoetin thrice weekly for chemotherapy induced anemia in nonhematological cancer patients
    Kotsori, A. A., Jr.
    Vaslamatzis, M. M.
    Alexopoulos, C. G.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [45] A PROSPECTIVE DATA AUDIT OF THE MANAGEMENT OF CHEMOTHERAPY-INDUCED ANEMIA WITH DARBEPOETIN ALFA - THE APRIORI STUDY
    Boguradzki, P.
    Boer, K.
    Cipkova, A.
    Wojciechowska-Lampka, E.
    Schuetzova, M.
    Ocvirk, J.
    Toth, E.
    ANNALS OF ONCOLOGY, 2012, 23 : 504 - 504
  • [46] Maintenance dosing with epoetin alfa every three weeks (Q3W) in anemic patients with cancer receiving chemotherapy every three weeks: Final results
    Montoya, VP
    Xie, J
    Woodman, RC
    BLOOD, 2005, 106 (11) : 992A - 992A
  • [47] DARBEPOETIN ALFA IN THE TREATMENT OF CHEMOTHERAPY-INDUCED ANAEMIA; EFFECTS OF TARGET HAEMOGLOBIN LABEL CHANGE: DATA FROM THE APRIORI STUDY
    Sarosi, V.
    Cipkova, A.
    Mocikova, H.
    Wojciechowska-Lampka, E.
    Ocvirk, J.
    Balazs, M.
    ANNALS OF ONCOLOGY, 2010, 21 : 386 - 386
  • [48] An evaluation of the effectiveness of darbepoetin alfa 300 mcg every 3 weeks (Q3W) on clinical outcomes in cancer patients with chemotherapy-induced anemia.
    Boccia, RV
    Liu, DL
    Silberstein, P
    Tchekmedyian, S
    Tomita, D
    Rossi, G
    Otterson, G
    BLOOD, 2004, 104 (11) : 412B - 413B
  • [49] The cost-effectiveness of weekly epoetin alfa relative to weekly darbepoetin alfa in patients with chemotherapy-induced anemia
    Ben-Hamadi, R
    Duh, MS
    Aggarwal, J
    Henckler, A
    McKenzie, RS
    Piech, CT
    CURRENT MEDICAL RESEARCH AND OPINION, 2005, 21 (10) : 1677 - 1682
  • [50] Cost and effectiveness of darbepoetin ALFA administered every 3 weeks (Q3W DA) compared with weekly epoetin ALFA (QW EA) or epoetin beta (QW EB) in patients (PTS) with chemotherapy-induced anemia (CIA): A retrospective study
    Coiffier, Bertrand
    Schlag, Rudolf
    Velasco, Amalia
    Yao, Bin
    Schupp, Marco
    Demarteau, Nadia
    Annemans, Lieven
    ANNALS OF ONCOLOGY, 2006, 17 : 293 - 293
12345